These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30882703)

  • 1. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Huangqi Guizhi Wuwutang granule in patients with rheumatoid arthritis.
    Wang Y; Liu Y; Xi Z; Yu Y; Liu L; Mao J; Xiao L; Gu X; Yao M; Cui X; Shi Q; Wang Y; Liang Q
    Medicine (Baltimore); 2019 Mar; 98(11):e14888. PubMed ID: 30882703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of the traditional Chinese medicine Juanbi pill combined with methotrexate in active rheumatoid arthritis: study protocol for a randomized controlled trial.
    Wang Q; Wang YR; Jia QY; Liu L; Xu CQ; Wang XY; Yao M; Cui XJ; Shi Q; Wang YJ; Liang QQ
    Trials; 2018 Mar; 19(1):188. PubMed ID: 29558967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of the traditional Chinese medicine Jia Wei Niu Bang Zi granule combined with methotrexate in treating active rheumatoid arthritis: A multicenter, randomized, double-blinded controlled clinical trial.
    Wang YR; Liu L; Wang XY; Wang Q; Yao M; Cui XJ; Mao JC; Liu J; Gu XH; Chen YL; Yu X; Shi Q; Liang QQ; Wang YJ
    Medicine (Baltimore); 2019 Feb; 98(6):e14424. PubMed ID: 30732199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation of the curative effect of Guizhi-Shaoyao-Zhimu decoction combined with methotrexate in the treatment of early rheumatoid arthritis based on ultrasonic evaluation: study protocol of a randomized, double-blind, controlled clinical trial.
    Shen J; Chen Q; Yang G; He Y
    Trials; 2021 Nov; 22(1):764. PubMed ID: 34732237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herbal medicine Xinfeng Capsule in treatment of rheumatoid arthritis: study protocol of a multicenter randomized controlled trial.
    Liu J; Huang CB; Wang Y; Xu GQ; Cheng YY; Feng YX; Liu L; Qi YJ
    J Integr Med; 2013 Nov; 11(6):428-34. PubMed ID: 24299607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the therapeutic efficacy of the Chinese herbal medicine Yishen Tongbi decoction in patients with active rheumatoid arthritis: protocol for a randomized, controlled, noninferiority trial.
    Zhao L; Li M; Xu Y; Liu L; Zhang M; Chen G
    Trials; 2019 Dec; 20(1):801. PubMed ID: 31888728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Tong Luo Hua Shi capsule, a modernized Tibetan medicine, in patients with rheumatoid arthritis.
    Liu W; Wu YH; Hu SY; Zhong CL; Gao ML; Liu DW; Wang HY; Chen MZ; Song YJ; Yang BZ; Zheng QS; Yao H; Qi XB; Li G
    Trials; 2016 Jul; 17():359. PubMed ID: 27465818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Will Chinese external therapy with compound Tripterygium wilfordii hook F gel safely control disease activity in patients with rheumatoid arthritis: design of a double-blinded randomized controlled trial.
    Jiang Q; Tang XP; Chen XC; Xiao H; Liu P; Jiao J
    BMC Complement Altern Med; 2017 Sep; 17(1):444. PubMed ID: 28870177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
    Cohen SB; Emery P; Greenwald MW; Dougados M; Furie RA; Genovese MC; Keystone EC; Loveless JE; Burmester GR; Cravets MW; Hessey EW; Shaw T; Totoritis MC;
    Arthritis Rheum; 2006 Sep; 54(9):2793-806. PubMed ID: 16947627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wangbi granule as a combination therapy to achieve clinical deep remission in rheumatoid arthritis: protocol for a multicenter, triple-blind, randomised, placebo-controlled trial.
    Wang J; Wang Z; Lan T; Zhang L; Li Z; Wang X; Zou Q; Wang Y; Li Y; Luo R; Zhang N; Xu Y; Li M; Tao Q
    Chin Med; 2023 Feb; 18(1):22. PubMed ID: 36855169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adalimumab plus methotrexate for the treatment of rheumatoid arthritis: a multi-center randomized, double-blind, placebo-controlled clinical study.].
    Huang F; Zhang FC; Bao CD; Tao Y; Gu JR; Xu JH; Zhu P; Xu HJ; Zhang ZY; Zhao DB; Wu DH
    Zhonghua Nei Ke Za Zhi; 2009 Nov; 48(11):916-21. PubMed ID: 20079321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of Taoren Honghua Jian granule in patients with stable coronary artery disease.
    Wang Y; Zhang Y; Du Y; Yang Y; Wei J; Zhang N; Mao M; Du W; Liu P
    Medicine (Baltimore); 2019 Nov; 98(44):e17753. PubMed ID: 31689832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial.
    Lee S; Cho Y; Kim J; Kang JW; Yoon GY; Lee JH; Jung SY; Kwon O; Shin KM; Lee JD
    Trials; 2018 Sep; 19(1):471. PubMed ID: 30176923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trial.
    Wei XM; Chen XF; Shu P; Jiang ZW; Wu XY; Zou X; Chen K; Shen B; Hu WW; Lu W; Shen WX; Li L; Wang JY; Zhao FJ; Yin QF; Cheng HB; Gu YH
    Medicine (Baltimore); 2020 May; 99(22):e19923. PubMed ID: 32481364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chinese medicine formula (kunbixiao granule) for female rheumatoid arthritis: Study protocol for a double-blind, randomized, placebo-controlled trial.
    Wan Y; Yang J; Ma T; Wang W; Wang H; Sun W; Ye W; Yang L; Ren J; Kou Q
    Front Pharmacol; 2022; 13():945565. PubMed ID: 36299880
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy and safety of Huangqi Guizhi Wuwu decoction for rheumatoid arthritis: A protocol for systematic review and meta-analysis.
    Wang L; Fan Y; Xin P; Zhao Y; Deng H; Jia B
    Medicine (Baltimore); 2020 Sep; 99(36):e22011. PubMed ID: 32899051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of comparative pain relief and tolerability of SKI306X compared with celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, double-dummy, phase III, noninferiority clinical trial.
    Song YW; Lee EY; Koh EM; Cha HS; Yoo B; Lee CK; Baek HJ; Kim HA; Suh Y; Kang SW; Lee YJ; Jung HG
    Clin Ther; 2007 May; 29(5):862-873. PubMed ID: 17697905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial.
    Abdallah MS; Alarfaj SJ; Saif DS; El-Naggar ME; Elsokary MA; Elsawah HK; Abdelsattar Zaki S; Wahsh EA; Abo Mansour HE; Mosalam EM
    Int Immunopharmacol; 2021 Jun; 95():107575. PubMed ID: 33773207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Golimumab, a human anti–tumor necrosis factor monoclonal antibody, injected subcutaneously every 4 weeks in patients with active rheumatoid arthritis who had never taken methotrexate: 1-year and 2-year clinical, radiologic, and physical function findings of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Emery P; Fleischmann RM; Doyle MK; Strusberg I; Durez P; Nash P; Amante E; Churchill M; Park W; Pons-Estel B; Xu W; Xu S; Wu Z; Hsia EC
    Arthritis Care Res (Hoboken); 2013 Nov; 65(11):1732-42. PubMed ID: 23861303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.